CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for curasan AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

curasan AG
Lindigstr. 4
Phone: +49 6027409000p:+49 6027409000 Kleinostheim, 63801  Germany Ticker: CURKCURK

This company is no longer actively traded on any major stock exchange.

Business Summary
curasan AG is a Germany-based developer, producer and marketer of medical products in the areas of bone and tissue regeneration. The Company focuses on dentistry products and orthopedics. In the dentistry area, the Company focuses on bone regeneration and wound healing, offering CERASORB, Osbone, stypro and foils and membranes, as well as accessories, such as fixation systems. In the orthopedics area, the Company offers CERASORB, stypro and Curavisc for bone regeneration, wound healing and osteoarthritis therapy. The CERASORB product family provides bone replacement material for bone defects. stypro is a sterile and porous sponge from biomaterial that is implantable and resorbable. Osbone is a synthetic open-cell cancellous bone graft material for filling bone defects and for augmentation of the atrophied alveolar ridge.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201912/31/2019Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Supervisory Board DetlefWilke
Chief Executive Officer AlexanderBaratta 3/16/2020 3/16/2020
Vice Chairman of the Supervisory Board Dirk T.Honold 51
5 additional Officers and Directors records available in full report.

Business Names
Business Name
0OQM
CUR
Curasan AG
4 additional Business Names available in full report.

General Information
Number of Employees: 36 (As of 12/31/2019)
Outstanding Shares: 9,065,873 (As of 12/31/2019)
Shareholders: 2,270
Stock Exchange: ETR
Fax Number: +49 60274090029


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023